Frank Bedu - Jun 15, 2021 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role: President/CEO, Director
Signature: /s/ Frank Bedu-Addo
Stock symbol: PDSB
Transactions as of: Jun 15, 2021
Transactions value $: -$2
Form type: 4
Date filed: 6/17/2021, 07:26 PM
Next filing: Jan 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PDSB	Common Stock	Options Exercise	$349K	+53.2K	+8.57%	$6.57	674K	Jun 15, 2021	Direct	F1
transaction	PDSB	Common Stock	Tax liability	-$349K	-27.2K	-4.03%	$12.86	647K	Jun 15, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PDSB	Stock Option (Right to Buy)	Options Exercise	$0	-53.2K	-100%	$0.00^*	0	Jun 15, 2021	Common Stock	53.2K	$6.57	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021.
F2	The Stock Option is fully vested in accordance with its terms.